Zealand Pharma A/S (CPH:ZEAL)
350.40
+9.30 (2.73%)
Aug 14, 2025, 4:59 PM CET
Zealand Pharma Employees
Zealand Pharma had 335 employees as of December 31, 2024. The number of employees increased by 82 or 32.41% compared to the previous year.
Employees
335
Change (1Y)
82
Growth (1Y)
32.41%
Revenue / Employee
23.66M DKK
Profits / Employee
17.35M DKK
Market Cap
24.21B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Genmab | 2,682 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Ambu A/S | 5,196 |
Bavarian Nordic | 1,605 |
Zealand Pharma News
- 11 hours ago - Zealand Pharma reports 1H results - Seeking Alpha
- 19 hours ago - Zealand Pharma Announces Financial Results for the First Half of 2025 - GlobeNewsWire
- 7 days ago - Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results - GlobeNewsWire
- 27 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 2 months ago - Zealand Pharma Obesity Therapy Shows Positive Trial Results - Market Watch
- 2 months ago - Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide - GlobeNewsWire
- 2 months ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 2 months ago - Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome - GlobeNewsWire